Percentage of adults and children enrolled in HIV care who were screened for hepatitis C

Export Indicator

Percentage of adults and children enrolled in HIV care who were screened for hepatitis C
What it measures

This indicator measures the number of people living with HIV enrolled in HIV care who were screened for HCV a/b with the purpose of addressing patient’s health needs regarding hepatitis C.

HIV patients are often co-infected with HCV, notably in the WHO European Region, due to the same modes of transmission of HIV and HCV. Screening of HCV informs physician strategy on patient management (further
evaluation and treatment of Hepatitis C if indicated or counselling on how to minimize risk of HCV infection in the future). This is part of a comprehensive approach to the management of PLHIV promoted in the WHO European
Region.

Rationale

HIV patients are often co-infected with HCV, notably in the WHO European Region, due to the same modes of transmission of HIV and HCV. Screening of HCV informs physician strategy on patient management (further
evaluation and treatment of Hepatitis C if indicated or counselling on how to minimize risk of HCV infection in the future). This is part of a comprehensive approach to the management of PLHIV promoted in the WHO European
Region.

Numerator

Number of adults and children enrolled in HIV care who were screened for hepatitis C using HCV a/b tests during the reporting year.

Denominator

Number of adults and children enrolled in HIV care.

Calculation

Numerator / Denominator

Method of measurement

The numerator and denominator are calculated from clinical records of health care facilities which provide HIV/AIDS treatment and care.

Data quality control and notes for the reporting tool:
National Representativeness: if this indicator is only produced in a sub-set of facilities, comment should be added on the source of information, sample size and whether the information is representative of all sites where
HIV/AIDS treatment and care delivered.

Measurement frequency
Disaggregation
Explanation of the numerator
Explanation of the denominator
Strengths and weaknesses

The strength of this indicator is that it allows countries to monitor the extend to which HIV infected patients are being screened for hepatitis B – an intervention that is critical for assessing further needs related to the
management of hepatitis C. Presence of HCV a/b provides information on HIV/HCV co-infection rates, informs clinicians on need for further clinical and laboratory evaluation and treatment.

Additional considerations: Additional information regarding the number of adults and children enrolled in HIV care and screened for hepatitis C, who were diagnosed with hepatitis C during the reporting year is also requested as part of this indicator. This data allows evaluating access to treatment among those who need it.

Data utilization: Look at trends over time. Useful information for clinical management and quality control in patient management.

Further information